Analysis of ASMs and male infertility using the FDA adverse event reporting system (FAERS)
Despite the limitations of the FAERS database, these findings emphasize the importance of monitoring reproductive health in male patients, particularly those of childbearing age, and highlight the need to balance ASM efficacy with potential reproductive toxicity in clinical practice. Further research is needed to validate these findings and explore underlying mechanisms.
Authors
- Xuezhi Liang (ORCID: https://orcid.org/0000-0002-2203-6958)
- Yujia Xi
- Kunyang An
- Xinfang Cao (ORCID: https://orcid.org/0009-0000-5859-0283)
- Jingqi Wang (ORCID: https://orcid.org/0000-0003-2820-1026)
- Xiaoqin Hu (ORCID: https://orcid.org/0000-0002-0950-9191)
- Jingyu Xu
Institutions
- Shanxi Medical University (CN)
- First Hospital of Shanxi Medical University (CN)
- Second Hospital of Shanxi Medical University (CN)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2026-01-26
- DOI
- https://doi.org/10.3389/fpubh.2025.1738546
- Primary Topic
- Pharmacological Effects and Toxicity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00